Exchange: NYSE
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 5/24/2013
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 1.12 | 0.92 | 21.24 |
| EPS, GAAP | 1.42 | 0.91 | 0.91 |
| Consensus Estimate | 1.05 | 0.79 | 33.76 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 3.81 | 4.49 | -15.15 |
| EPS, GAAP | 3.66 | 3.90 | -6.24 |
| Consensus Estimate | 3.33 | 4.35 | -23.54 |
| LLY | Industry Average | |
| P/E (TTM) | 12.95 | NA |
| P/E (Forward) | 13.89 | NA |
| PEG Ratio | 395.86 | 20.55 |
| Price/Sales | 2.63 | 8.19 |
| Beta | 0.19 | 0.65 |
| 9:28 AM | 5/14/2013 | Lilly CEO Recovering From Surgery for Dilated Aorta |
| 8:58 AM | 5/10/2013 | Eli Lilly Ends Development of Lymphoma Drug Enzastaurin; Missed Study Endpoint |
| 5/14/2013 | Merrill Lynch Large Cap Pharmaceutical Stocks to Buy (24/7 Wall St) |
| 5/7/2013 | Baxter Can Bounce Back (Barrons.com) |
| 5/7/2013 | Viagra for Sale Online: Will Other Drug Companies Follow Pfizer? (24/7 Wall St) |
| 5/7/2013 | Will Cialis and Levitra Sell Online? (24/7 Wall St) |
| 5/6/2013 | Lilly CEO to Have Artery Surgery (WSJ.com) |
| 5/6/2013 | The Top Seven Drugs with U.S. Quarterly Sales Over $1 Billion (24/7 Wall St) |
| 4/29/2013 | Research Reports (Barrons.com) |
| 4/27/2013 | Welcome to Drug R&D's Golden Age (Barrons.com) |
